Mannosylated SLN appears to be promising as carrier for vaccine delivery against hepatitis B as ascertained by in vitro and in vivo studies, however further investigations on humans are required to establish their potential as vaccines against hepatitis B infection.
No takes yet. Share an insight, caveat, or question.
Mishra et al. (2010) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: